Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80

被引:37
作者
Kurakhmaeva, K. B. [1 ]
Voronina, T. A. [1 ]
Kapica, I. G. [1 ]
Kreuter, J.
Nerobkova, L. N. [1 ]
Seredenin, S. B. [1 ]
Balabanian, V. Yu. [2 ,3 ]
Alyautdin, R. N. [2 ,3 ]
机构
[1] Russian Acad Med Sci, VV Zakusov State Res Inst Pharmacol, Moscow 109801, Russia
[2] Univ Frankfurt, Inst Pharmaceut Technol, Frankfurt, Germany
[3] IM Sechenov Moscow Med Acad, Pharmaceut Fac, Dept Pharmacol, Moscow, Russia
关键词
nerve growth factor; polybutylcyanoacrylate nanoparticles coated with polysorbate-80; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Parkinsonian disease;
D O I
10.1007/s10517-008-0065-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The study examined the antiparkinsonian effect of nerve growth factor adsorbed on the surface of polybutylcyanoacrylate nanoparticles coated with polysorbate-80 surfactant. The parkinsonian syndrome in C57B1/6 mice was provoked by intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. The basic symptoms of the parkinsonian syndrome decreased under the action of the nerve growth factor adsorbed on nanoparticles coated with polysorbate-80, which was seen from decreased rigidity and increased locomotor activity compared to control mice receiving with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine alone. This effect of nerve growth factor on nanoparticles persisted after 7 and 21 days after single injection of the neurotoxin. These data attest to the possibility of using nanoparticles prepared from amphiphilic polymers and coated with polysorbate-80 for the delivery of nerve growth factor into the brain during systemic treatment.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 15 条
[1]  
BASSEL AA, 2005, EKSP KLIN FARMAKOL, V68, P3
[2]  
Blochl A, 1996, J BIOL CHEM, V271, P21100
[3]   Nerve growth factor favours long-term depression over long-term potentiation in layer II-III neurones of rat visual cortex [J].
Brancucci, A ;
Kuczewski, N ;
Covaceuszach, S ;
Cattaneo, A ;
Domenici, L .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 559 (02) :497-506
[4]   Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease [J].
Chaturvedi, RK ;
Shukla, S ;
Seth, K ;
Agrawal, AK .
NEUROSCIENCE LETTERS, 2006, 398 (1-2) :44-49
[5]   Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro [J].
Eggert, K ;
Schlegel, J ;
Oertel, W ;
Würz, C ;
Krieg, JC ;
Vedder, H .
NEUROSCIENCE LETTERS, 1999, 269 (03) :178-182
[6]   Chronic oral estrogen affects memory and neurochemistry in middle-aged female mice [J].
Fernandez, SA ;
Frick, KA .
BEHAVIORAL NEUROSCIENCE, 2004, 118 (06) :1340-1351
[7]   VENTRICULAR INJECTION OF NERVE GROWTH-FACTOR INCREASES DOPAMINE CONTENT IN THE STRIATA OF MPTP-TREATED MICE [J].
GARCIA, E ;
RIOS, C ;
SOTELO, J .
NEUROCHEMICAL RESEARCH, 1992, 17 (10) :979-982
[8]   Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma [J].
Gelperina, SE ;
Khalansky, AS ;
Skidan, IN ;
Smirnova, ZS ;
Bobruskin, AI ;
Severin, SE ;
Turowski, B ;
Zanella, FE ;
Kreuter, J .
TOXICOLOGY LETTERS, 2002, 126 (02) :131-141
[9]   Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man [J].
Gerlach, M ;
Riederer, P .
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (8-9) :987-1041
[10]  
Humpel C, 2002, J NEURAL TRANSM-SUPP, P253